από Vangelis Argiriou | Νοέ 25, 2021 | Uncategorized
The results of a clinical trial published in the New England Journal of Medicine show that two 10-μg doses of the BNT162b2 vaccine administered 21 days apart in children aged five to 11 years produced a robust virus-neutralising response, being 90.7 per cent effective...
από Vangelis Argiriou | Φεβ 13, 2021 | Uncategorized
A report examines if the influenza and pneumococcal vaccine has a protective effect against COVID-19. As the coronavirus disease 2019 (COVID-19) pandemic moved into the traditional influenza season, there was a strong drive to administer the flu shot to as many...
από Vangelis Argiriou | Φεβ 13, 2021 | Uncategorized
A new study, published in The Lancet Child & Adolescent Health, adds to evidence that young children are not “super-spreaders” of SARS-CoV-2. Researchers measured SARS-CoV-2 antibodies among roughly 300 children under age 5 years and 200 staff members...
από Vangelis Argiriou | Ιαν 17, 2021 | Uncategorized
January 4, 2021 Deborah Lehman, MD reviewing Ronchi A et al. JAMA Pediatr 2020 Dec 7 In an Italian study, breast-feeding and rooming-in were safely practiced with precautions to minimize risk for viral transmission. Italy experienced high rates of COVID-19 early in...
